Stocks and Investing Stocks and Investing
Tue, December 3, 2024
[ Tue, Dec 03rd 2024 ] - Thomas Matters
This Vanguard ETF Is Up 32% in 2024. Here's Why I .. nt Alphabet, Meta Platforms, Netflix, and Disney.
[ Tue, Dec 03rd 2024 ] - Thomas Matters
The Stock Market Has Done This Just 10 Times in 30 Years, and It May Signal a Big Move in 2025
[ Tue, Dec 03rd 2024 ] - Thomas Matters
Robinhood Is Taking on Charles Schwab and Fidelity. What It Means for the Stock.
[ Tue, Dec 03rd 2024 ] - Thomas Matters
What is Cryptocurrency and How Does it Work?
[ Tue, Dec 03rd 2024 ] - Thomas Matters
A 7% dividend yield but down 16%! Is this mining giant a no-brainer?
[ Tue, Dec 03rd 2024 ] - Thomas Matters
Lululemon Athletica: Strong Growth Prospects Driven by Chinese Market and E-commerce Expansion
[ Tue, Dec 03rd 2024 ] - Thomas Matters
Jeff Bezos is betting millions on a Nvidia rival
[ Tue, Dec 03rd 2024 ] - Thomas Matters
An active 'ethical' MF scheme comes to market aft .. ears. Chirag Mehta of Quantum MF explains trigger
[ Tue, Dec 03rd 2024 ] - Thomas Matters
Top 10 mutual funds to invest in December 2024
[ Tue, Dec 03rd 2024 ] - Thomas Matters
2 fantastic ASX growth stocks to buy and hold for 10 years
Mon, December 2, 2024
[ Mon, Dec 02nd 2024 ] - Thomas Matters
What is an IPO?
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Boeing: Selling $83 Billion Of Inventories Is Essential To A Stronger Buy
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Hedge funds profit from 'Trump trades' around US election
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Thesis Gold Upsizes Previously-Announced Private Placement To $10 Million
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Buying ASX 200 dividend stocks? Here's what to expect in 2025
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Why Wolfspeed Stock Is Soaring Today
[ Mon, Dec 02nd 2024 ] - Thomas Matters
1 Historically Cheap Stock-Split Stock to Buy Han .. Artificial Intelligence (AI) Stock Split to Avoid
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Peter Brandt Hints At Litecoin Price Rally To $420 Mirroring XRP's Path
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Nvidia Bought 6 Artificial Intelligence (AI) Stocks, but This 1 Has Soared the Most
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Here's Why Fiserv (FI) is a Strong Growth Stock
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Warren Buffett Owns 1 Vanguard ETF That Could Be .. to Plunge, According to a Top Wall Street Analyst
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Muni Bond Funds Are Attractive Now If You Have Large Taxable Assets
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Stock Market News: Dow Drops, Nasdaq Heads to New Record
[ Mon, Dec 02nd 2024 ] - Thomas Matters
TBG: A New And Promising Dividend Growth ETF
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Why Rio Tinto shares are my top ASX mining sector buy
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Unusually active option classes on open December 2nd
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Here's Why News Corp. (NWSA) is a Strong Momentum Stock
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Xplore Appoints Telecom Industry Leader Brent Johnston as CEO
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Looking for an ASX dividend stock with a yield of over 10%? I'd buy this one
[ Mon, Dec 02nd 2024 ] - Thomas Matters
Why Is Merck & Co., Inc. (MRK) Among the Stocks Ray Dalio's Bridgewater Is Crazy About?

Why Is Merck & Co., Inc. (MRK) Among the Stocks Ray Dalio's Bridgewater Is Crazy About?


Published on 2024-12-02 17:01:18 - Thomas Matters, WOPRAI
  Print publication without navigation

  • We recently compiled a list of the Billionaire Ray Dalio's Bridgewater Is Crazy About These 15 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Ray Dalio's Bridgewater is crazy about.

The article discusses why Merck & Co., Inc. (MRK) is a favored stock among Ray Dalio's hedge fund, Bridgewater Associates. Merck has shown robust financial performance with a 7% year-over-year revenue increase in Q1 2024, driven by strong sales of its cancer drug Keytruda and vaccines like Gardasil. The company's strategic focus on oncology, with Keytruda expected to remain a significant revenue driver until at least 2028, underpins its attractiveness. Additionally, Merck's pipeline includes promising new treatments, and its recent acquisitions, like Prometheus Biosciences, are aimed at expanding its immunology portfolio. Bridgewater's interest in Merck also reflects confidence in the company's ability to navigate patent expirations and maintain growth through innovation and strategic acquisitions.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/other/why-is-merck-co-inc-mrk-among-the-stocks-ray-dalio-s-bridgewater-is-crazy-about/ar-AA1v7ppq ]
Contributing Sources